Clinical Trial Update: A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating Gliadel implants with concurrent temozolomide and radiation, followed by dose-dense temozolomide, for newly diagnosed ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• High-grade Glioma

Drugs mentioned

• GLIADEL (Carmustine)
• Temodar (Temozolomide)

Snippet

Sponsor: Kentuckiana Cancer Institute | Conditions: Glioma | Phase 2 | Status: UNKNOWN